인플루엔자 백신 시장은 2023-2028년 37억 6,180만 달러로 예측되며, 예측 기간 동안 8.09%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 인플루엔자 백신 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 독감 유행과 발병률 증가, 독감 예방접종에 대한 인식 증가, 예방접종 프로그램 및 연구 활동의 시작에 의해 시장이 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024년 |
| 종료 연도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 전년 대비[2024년] |
7.32% |
| CAGR |
8.09% |
| 증분 금액 |
37억 6,180만 달러 |
이 보고서는 향후 몇 년 동안 인플루엔자 백신 시장의 성장을 촉진하는 주요 이유 중 하나로 재접종의 필요성을 꼽았습니다. 또한, 독감 바이러스의 유전적 특성 분석 연구의 급증과 전 세계 여행자 수의 증가는 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 시장 상황
제3장 시장 규모 평가
- 시장 정의
- 시장 부문 분석
- 시장 규모 2023년
- 시장 전망 2023-2028년
제4장 시장 규모 실적
- 인플루엔자 백신 세계 시장 2018-2022년
- 유통 채널별 부문 분석 2018-2022년
- 유형별 부문 분석 2018-2022년
- 지역별 부문 분석 2018-2022년
- 국가별 부문 분석 2018-2022년
제5장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제6장 시장 세분화 : 유통 채널별
- 시장 세분화
- 비교 : 유통 채널별
- 병원과 약국 : 시장 규모와 예측 2023-2028년
- 정부와 기관 : 시장 규모와 예측 2023-2028년
- 기타 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 유통 채널별
제7장 시장 세분화 : 유형별
- 시장 세분화
- 비교 : 유형별
- 생약독 인플루엔자 백신 : 시장 규모와 예측 2023-2028년
- 재조합 인플루엔자 백신 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 유형별
제8장 고객 상황
제9장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2023-2028년
- 유럽 : 시장 규모와 예측 2023-2028년
- 아시아 : 시장 규모와 예측 2023-2028년
- 기타 : 시장 규모와 예측 2023-2028년
- 미국 : 시장 규모와 예측 2023-2028년
- 영국 : 시장 규모와 예측 2023-2028년
- 중국 : 시장 규모와 예측 2023-2028년
- 캐나다 : 시장 규모와 예측 2023-2028년
- 인도 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 지역 상황별
제10장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제11장 경쟁 상황
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Altimmune Inc.
- AstraZeneca Plc
- Baxter International Inc.
- BiondVax Pharmaceuticals Ltd.
- CSL Ltd.
- FluGen Inc.
- GlaxoSmithKline Plc
- Mitsubishi Chemical Group Corp.
- Novavax Inc.
- Pfizer Inc.
- Sanofi SA
- Shijiazhuang Yiling Pharmaceutical Co Ltd.
- SK Chemicals Co. Ltd.
- Vaccitech Plc
- Vaxart Inc.
제13장 부록
ksm
The influenza vaccine market is forecasted to grow by USD 3761.8 mn during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the influenza vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence and incidence of influenza, rising awareness about influenza vaccination, and initiation of immunization programs and research activities.
Technavio's influenza vaccine market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 7.32% |
| CAGR | 8.09% |
| Incremental Value | $3761.8 mn |
By Distribution Channel
- Hospitals and pharmacies
- Government and institutional
- Others
By Type
- Live attenuated influenza vaccines
- Recombinant influenza vaccines
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the need for revaccination as one of the prime reasons driving the influenza vaccine market growth during the next few years. Also, surge in number of genetic characterization studies on influenza virus and increase in global travel will lead to sizable demand in the market.
The report on the influenza vaccine market covers the following areas:
- Influenza vaccine market sizing
- Influenza vaccine market forecast
- Influenza vaccine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza vaccine market vendors that include Altimmune Inc., AstraZeneca Plc, Baxter International Inc., BioDiem Ltd., BiondVax Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., FluGen Inc., GlaxoSmithKline Plc, Mitsubishi Chemical Group Corp., Novavax Inc., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Shijiazhuang Yiling Pharmaceutical Co Ltd., SK Chemicals Co. Ltd., Vaccitech Plc, Vaxart Inc., and Vaxine Pty Ltd.. Also, the influenza vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Influenza Vaccine Market 2018 - 2022
- Historic Market Size - Data Table on Global Influenza Vaccine Market 2018 - 2022 ($ million)
- 4.2 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
- 4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
- 6.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
- 6.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 6.3 Hospitals and pharmacies - Market size and forecast 2023-2028
- Chart on Hospitals and pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals and pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals and pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals and pharmacies - Year-over-year growth 2023-2028 (%)
- 6.4 Government and institutional - Market size and forecast 2023-2028
- Chart on Government and institutional - Market size and forecast 2023-2028 ($ million)
- Data Table on Government and institutional - Market size and forecast 2023-2028 ($ million)
- Chart on Government and institutional - Year-over-year growth 2023-2028 (%)
- Data Table on Government and institutional - Year-over-year growth 2023-2028 (%)
- 6.5 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Type
- 7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 7.3 Live attenuated influenza vaccines - Market size and forecast 2023-2028
- Chart on Live attenuated influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Data Table on Live attenuated influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Chart on Live attenuated influenza vaccines - Year-over-year growth 2023-2028 (%)
- Data Table on Live attenuated influenza vaccines - Year-over-year growth 2023-2028 (%)
- 7.4 Recombinant influenza vaccines - Market size and forecast 2023-2028
- Chart on Recombinant influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Data Table on Recombinant influenza vaccines - Market size and forecast 2023-2028 ($ million)
- Chart on Recombinant influenza vaccines - Year-over-year growth 2023-2028 (%)
- Data Table on Recombinant influenza vaccines - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.11 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Altimmune Inc.
- Altimmune Inc. - Overview
- Altimmune Inc. - Product / Service
- Altimmune Inc. - Key news
- Altimmune Inc. - Key offerings
- 12.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.5 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- 12.6 BiondVax Pharmaceuticals Ltd.
- BiondVax Pharmaceuticals Ltd. - Overview
- BiondVax Pharmaceuticals Ltd. - Product / Service
- BiondVax Pharmaceuticals Ltd. - Key offerings
- 12.7 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- 12.8 FluGen Inc.
- FluGen Inc. - Overview
- FluGen Inc. - Product / Service
- FluGen Inc. - Key offerings
- 12.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- 12.10 Mitsubishi Chemical Group Corp.
- Mitsubishi Chemical Group Corp. - Overview
- Mitsubishi Chemical Group Corp. - Business segments
- Mitsubishi Chemical Group Corp. - Key news
- Mitsubishi Chemical Group Corp. - Key offerings
- Mitsubishi Chemical Group Corp. - Segment focus
- 12.11 Novavax Inc.
- Novavax Inc. - Overview
- Novavax Inc. - Product / Service
- Novavax Inc. - Key offerings
- 12.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 12.13 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- 12.14 Shijiazhuang Yiling Pharmaceutical Co Ltd.
- Shijiazhuang Yiling Pharmaceutical Co Ltd. - Overview
- Shijiazhuang Yiling Pharmaceutical Co Ltd. - Product / Service
- Shijiazhuang Yiling Pharmaceutical Co Ltd. - Key offerings
- 12.15 SK Chemicals Co. Ltd.
- SK Chemicals Co. Ltd. - Overview
- SK Chemicals Co. Ltd. - Product / Service
- SK Chemicals Co. Ltd. - Key news
- SK Chemicals Co. Ltd. - Key offerings
- 12.16 Vaccitech Plc
- Vaccitech Plc - Overview
- Vaccitech Plc - Product / Service
- Vaccitech Plc - Key offerings
- 12.17 Vaxart Inc.
- Vaxart Inc. - Overview
- Vaxart Inc. - Product / Service
- Vaxart Inc. - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 Data procurement
- 13.6 Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
